The congenital heart surgeon frequently encounters patients with various genetic disorders requiring surgical intervention. Although the specifics of the genetics for these patients and their families lie in the purview of specialists in genetics, the surgeon is well-served to be familiar with aspects of specific syndromes that impact surgical management and perioperative care. This aids in counseling families in expectations for the hospital course and recovery as well as can impact intraoperative and surgical management. This review article summarizes key characteristics for the congenital heart surgeon to be familiar with for common genetic disorders as they help coordinate care.
MorrishAMSmithJEnriquezA, et al.A new era of genetic testing in congenital heart disease: a review. Trends Cardiovasc Med.2022;32(5):311-319.
2.
KimDSKimJHBurtAA, et al.Burden of potentially pathologic copy number variants is higher in children with isolated congenital heart disease and significantly impairs covariate-adjusted transplant-free survival. J Thorac Cardiovasc Surg. 2016;151(4):1147-1151. e1144.
3.
BoskovskiMTHomsyJNathanM, et al.De Novo damaging variants, clinical phenotypes, and post-operative outcomes in congenital heart disease. Circ Genom Precis Med. 2020;13(4):e002836.
4.
MorrisJKMuttonDEAlbermanE. Revised estimates of the maternal age specific live birth prevalence of down’s syndrome. J Med Screen. 2002;9(1):2-6.
5.
IrvingCRichmondSWrenCLongsterCEmbletonND. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med. 2011;24(1):137-141.
6.
de GraafGBuckleyFSkotkoBG. Estimation of the number of people with down syndrome in the United States. Genet Med. 2017;19(4):439-447.
7.
FreemanSBTaftLFDooleyKJ, et al.Population-based study of congenital heart defects in down syndrome. Am J Med Genet. 1998;80(3):213-217.
8.
ShottSR. Down syndrome: analysis of airway size and a guide for appropriate intubation. Laryngoscope. 2000;110(4):585-592.
9.
BullMJ. Down syndrome. N Engl J Med. 2020;382(24):2344-2352.
10.
CohenWI. Current dilemmas in down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability. Am J Med Genet C Semin Med Genet. 2006;142C(3):141-148.
11.
AsimAKumarAMuthuswamySJainSAgarwalS. Down syndrome: an insight of the disease. J Biomed Sci. 2015;22(1):41.
12.
RasmussenSAWongLYYangQMayKMFriedmanJM. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics. 2003;111(4 Pt 1):777-784.
13.
MeyerRELiuGGilboaSM, et al.National Birth Defects Prevention Network. Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study. Am J Med Genet A. 2016;170A(4):825-837.
14.
CeredaACareyJC. The trisomy 18 syndrome. Orphanet J Rare Dis. 2012;7:81.
15.
CourregesPNieuviartsRLecoutreD. Anaesthetic management for Edward’s syndrome. Paediatr Anaesth. 2003;13(3):267-269.
16.
WeaverMSAndersonVBeckJ, et al.Interdisciplinary care of children with trisomy 13 and 18. Am J Med Genet A. 2021;185(3):966-977.
17.
KosivKAGossettJMBaiSCollinsRTII. Congenital heart surgery on in-hospital mortality in trisomy 13 and 18. Pediatrics. 2017;(5):e20170772.
18.
PetersonJKKochilasLKCattonKGMollerJHSettySP. Long-term outcomes of children with trisomy 13 and 18 after congenital heart disease interventions. Ann Thorac Surg. 2017;103(6):1941-1949.
19.
CarvajalHGCallahanCPMillerJRRensinkBLEghtesadyP. Cardiac surgery in trisomy 13 and 18: a guide to clinical decision-making. Pediatr Cardiol. 2020;41(7):1319-1333.
20.
GravholtCHViuffMHBrunSStochholmKAndersenNH. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019;15(10):601-614.
21.
GravholtCHLandin-WilhelmsenKStochholmK, et al.Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young.2006;16(5):430-436.
22.
StoutKKDanielsCJAboulhosnJA, et al.2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;139(14):e698-e800.
23.
MaranhaoMV. Turner syndrome and anesthesia. Rev Bras Anestesiol. 2008;58(1):84-89.
24.
BottoLDMayKFernhoffPM, et al.A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112(1 Pt 1):101-107.
25.
SullivanKE. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol. 2004;4(6):505-512.
26.
VorstmanJASMorcusMEJDuijffSN, et al.The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry. 2006;45(9):1104-1113.
MilosavljevicDOverwaterETammingaS, et al.Two cases of RIT1 associated Noonan syndrome: further delineation of the clinical phenotype and review of the literature. Am J Med Genet A. 2016;170(7):1874-1880.
StephensEHDearaniJAJohnsonJNAckermanMJOmmenSRSchaffHV. The surgeon’s view of the left ventricular outflow tract in congenital heart surgery. World J Pediatr Congenit Heart Surg. 2020;11(5):595-610.
31.
AndelfingerGMarquisCRaboissonMJ, et al.Hypertrophic cardiomyopathy in Noonan syndrome treated by MEK-inhibition. J Am Coll Cardiol. 2019;73(17):2237-2239.
32.
HsuPMaAWilsonM, et al.CHARGE syndrome: a review. J Paediatr Child Health. 2014;50(7):504-511.
33.
BlakeKMacCuspieJHartshorneTSRoyMDavenportSLCorstenG. Postoperative airway events of individuals with CHARGE syndrome. Int J Pediatr Otorhinolaryngol. 2009;73(2):219-226.
34.
StackCGWyseRK. Incidence and management of airway problems in the CHARGE association. Anaesthesia. 1991;46(7):582-585.
35.
CollinsRTII. Cardiovascular disease in Williams syndrome. Curr Opin Pediatr. 2018;30(5):609-615.
36.
LathamGJRossFJEissesMJRichardsMJGeiduschekJMJoffeDC. Perioperative morbidity in children with elastin arteriopathy. Paediatr Anaesth. 2016;26(9):926-935.
37.
PoberBR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239-252.
BassonCTCowleyGSSolomonSD, et al.The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med. 1994;330(13):885-891.
40.
ChryssostomidisGKanakisMFotiadouV, et al.Diversity of congenital cardiac defects and skeletal deformities associated with the Holt-Oram syndrome. Int J Surg Case Rep. 2014;5(7):389-392.
41.
GoellerJKVenezianoGTobiasJD. Perioperative management of a patient with Jacobsen syndrome. Pediatr Anesthesia Crit Care J. 2015;3(1):26-31.
42.
SoJStockleyTStavropoulosDJ. Periventricular nodular heterotopia and transverse limb reduction defect in a woman with interstitial 11q24 deletion in the Jacobsen syndrome region. Am J Med Genet A. 2014;164A(2):511-515.
43.
Linares ChavezEPToral LopezJValdes MirandaJM, et al.Jacobsen syndrome: surgical complications due to unsuspected diagnosis, the importance of molecular studies in patients with craniosynostosis. Mol Syndromol. 2016;6(5):229-235.
BonielSSzymanskaKSmigielRSzczalubaK. Kabuki syndrome—clinical review with molecular aspects. Genes (Basel). 2021;12(4).
46.
AdamMPBankaSBjornssonHT, et al.Kabuki syndrome medical advisory B. Kabuki syndrome: international consensus diagnostic criteria. J Med Genet. 2019;56(2):89-95.
47.
LindsleyAWSaalHMBurrowTA, et al.Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome. J Allergy Clin Immunol. 2016;137(1):179-187. e110.
48.
HillsCBKochilasLSchimmentiLAMollerJH. Ellis-van Creveld syndrome and congenital heart defects: presentation of an additional 32 cases. Pediatr Cardiol. 2011;32(7):977-982.
